Consumer willingness to pay for a hypothetical Chagas disease vaccine in Brazil: a cross-sectional study and the implications

Author:

Athie Thannuse Silva1ORCID,Nascimento Gesiane Cavalcante1ORCID,Labis da Costa Maria José1ORCID,Sales Silva Juliana de2ORCID,Reis Edna Afonso34ORCID,Martin Antony Paul56ORCID,Godman Brian789ORCID,Dias Godói Isabella Piassi14ORCID

Affiliation:

1. Institute of Health & Biological Studies – Universidade Federal do Sul e Sudeste do Pará, Avenida dos Ipês, s/n, Cidade Universitária, Cidade Jardim, Marabá, Pará, Brazil

2. Institute of Studies in Agricultural & Regional Development – Universidade Federal do Sul e Sudeste do Pará, Avenida dos Ipês, s/n, Cidade Universitária, Cidade Jardim, Marabá, Pará, Brazil

3. Department of Statistics, Exact Sciences Institute, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil

4. Researcher of the Group (CNPq) for Epidemiological, Economic & Pharmacological Studies of Arboviruses (EEPIFARBO), Universidade Federal do Sul e Sudeste do Pará, Avenida dos Ipês, s/n, Cidade Universitária, Cidade Jardim, Marabá, Pará, Brazil

5. Faculty of Health & Life Sciences, Brownlow Hill, Liverpool, L69 3BX, UK

6. QC Medica, York, North Yorkshire, YO23 2BD, UK

7. Department of Pharmacoepidemiology, Institute of Pharmacy & Biomedical Sciences, 161 Cathedral Street, Glasgow G4 0RE, UK

8. Division of Clinical Pharmacology, Karolinska Institute, Karolinska University Hospital, Stockholm SE-141 86, Sweden

9. Department of Public Health & Pharmacy Management, School of Pharmacy, Sefako Health Sciences University, Pretoria, South Africa

Abstract

Aim: Chagas disease is a serious public health problem, endemic in 21 countries in Latin America. A future vaccine can contribute to decreasing the number of cases and its complications. Methods: A cross-sectional study was conducted with residents of the northern region of Brazil, on the willingness to pay for a hypothetical vaccine against Chagas disease (effective protection of 80%). Results: We interviewed 619 individuals and seven were excluded from the analysis and the value of willingness to pay was US$23.77 (100.00 BRL). Conclusion: The Northern region of Brazil is one of the largest markets for this vaccine, due to its epidemiological relevance, so economic studies with this vaccine will be important to assist in the assessment of technologies.

Publisher

Future Medicine Ltd

Subject

Health Policy

Reference68 articles.

1. OPAS. Tropical Diseases (2018). www.paho.org/bra/index.php?option=com_joomlabook&view=topic&id=57&ite.mid=232

2. Brasil. Doenças Negligenciadas (2013). https://agencia.fiocruz.br/doenças-negligenciadas

3. Drugs for Neglected Diseases Initiative. Neglected Patients (2019). www.dndial.org/

4. Fundação Oswaldo Cruz. Conheça as principais doenças tropicais negligenciadas (2012). www.fiocruz.br/ioc/cgi/cgilua.exe/sys/start.htm?infoid=1585&sid=32

5. Mortality Trends for Neglected Tropical Diseases in the State of Sergipe, Brazil, 1980–2013

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3